Gland Pharma Limited — Others, 27-06-2025: Trading Window

Gland Pharma has announced a board meeting to consider the financial results for the quarter and half-year ending June 30, 2025. The trading window for dealing in the company’s securities will be closed until 48 hours after the results are declared. This trading restriction supports compliance with insider trading norms and maintains market integrity ahead of the earnings announcement, ensuring fair trading for all shareholders.